부산대학교 도서관

Brooks J; Deans A; Beier J; van Noord J; Cahn A; Mehta R; Baggen S; Maden C

International Journal of COPD, Vol 2012, Iss default, Pp 153-164 (2012)

Daley-Yates PT; GSK, 980 Great West Rd, Brentford, Middlesex, TW8 9GS, UK.; Deans A; GSK, Gunnels Wood Rd, Stevenage, Hertfordshire, SG1 2NY, UK. Electronic address: amanda.t.deans@gsk.com.; Mehta R; GSK, 5 Moore Drive, Research Triangle Park, NC, 27709, USA. Electronic address: rashmi.s.mehta@gsk.com.; Sousa AR; GSK, 980 Great West Rd, Brentford, Middlesex, TW8 9GS, UK. Electronic address: ana.x.sousa@gsk.com.

Publisher: Academic Press Country of Publication: England NLM ID: 9715279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-9629 (Electronic) Linking ISSN: 10945539 NLM ISO Abbreviation: Pulm Pharmacol Ther Subsets: MEDLINE

Collinson S; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.; Deans A; Urgent Care, Team Medical, Paraparaumu, New Zealand.; Padua-Zamora A; Department of Pediatrics, University of the Philippines Manila College of Medicine-Philippine General Hospital, Manila, Philippines.; Gregorio GV; Department of Pediatrics, University of the Philippines Manila College of Medicine-Philippine General Hospital, Manila, Philippines.; Li C; Tropical Clinical Trials Unit, Liverpool School of Tropical Medicine, Liverpool, UK.; Dans LF; Department of Pediatrics, University of the Philippines Manila College of Medicine-Philippine General Hospital, Manila, Philippines.; Allen SJ; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.

Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X (Electronic) Linking ISSN: 13616137 NLM ISO Abbreviation: Cochrane Database Syst Rev Subsets: MEDLINE

Begg M; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Wilson R; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Hamblin JN; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Montembault M; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Green J; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Deans A; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Amour A; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Worsley S; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Fantom K; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Cui Y; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Dear G; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Ahmad S; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Kielkowska A; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Clark J; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Boyce M; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Cahn A; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom.; Hessel EM; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage (M.Be., J.N.H., A.A., E.M.H.); GlaxoSmithKline, Stevenage (R.W., J.G., K.F., A.C.); GlaxoSmithKline, Stockley Park, Uxbridge (M.M., A.D., S.W., Y.C.); GlaxoSmithKline, Ware (G.D., S.A.); Babraham Institute, Babraham (A.K., J.C.); and Hammersmith Medicines Research, London (M.Bo.), United Kingdom edith.m.hessel@gsk.com.

Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE

Maclay JD; McAllister DA; Johnston S; Raftis J; McGuinnes C; Deans A; Newby DE; Mills NL; Macnee W; Maclay, John D; McAllister, David A; Johnston, Shonna; Raftis, Jennifer; McGuinnes, Catherine; Deans, Andrew; Newby, David E; Mills, Nicholas L; MacNee, William

Thorax (THORAX), Sep2011; 66(9): 769-774. (6p)

Meek R; Doherty S; Deans A

Emergency Medicine Australasia (EMERG MED AUSTRALAS), Aug2009; 21(4): 323-328. (6p)

Erskine JAK; Institute of Education, St George's, University of London, UK. Electronic address: JErskine@sgul.ac.uk.; Georgiou GJ; Department of Psychology & Sport Sciences, University of Hertfordshire, UK.; Joshi M; Institute of Education, St George's, University of London, UK.; Deans A; Institute of Education, St George's, University of London, UK.; Colegate C; Institute of Education, St George's, University of London, UK.

Publisher: Academic Press Country of Publication: United States NLM ID: 9303140 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2376 (Electronic) Linking ISSN: 10538100 NLM ISO Abbreviation: Conscious Cogn Subsets: MEDLINE

Cahn A; Medicines Discovery and Development, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK. tony.x.cahn@gsk.com; Tal-Singer R; Pouliquen IJ; Mehta R; Preece A; Hardes K; Crater G; Deans A

Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE

Giavedoni S; ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, Scotland, UK.; Deans A; McCaughey P; Drost E; MacNee W; Rabinovich RA

Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3064 (Electronic) Linking ISSN: 09546111 NLM ISO Abbreviation: Respir Med Subsets: MEDLINE

Mabee P; Department of Biology, University of South Dakota, Vermillion, SD, USA.; Deans A; Huala E; Lewis SE

Publisher: Biomed Central Country of Publication: England NLM ID: 101530505 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1944-3277 (Print) Linking ISSN: 19443277 NLM ISO Abbreviation: Stand Genomic Sci Subsets: PubMed not MEDLINE